Abacus Planning Group, Inc. Organon & Co. Transaction History

Abacus Planning Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$31.66 - $38.9 $379,065 - $465,749	-11,973 Closed	0 $0
Q1 2022 Apr 13, 2022	SELL	$30.45 - $39.36 $54,992 - $71,084	-1,806 Reduced 13.11%	11,973 $418,000
Q4 2021 Jan 18, 2022	BUY	$28.67 - $37.13 $395,043 - $511,614	13,779 New	13,779 $420,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Abacus Planning Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Abacus Planning Group, Inc. with notifications on news.